Evidence map›Paper›PMID 37138750›Full record

ArticleFrontiers in medicine2023

Cardiovascular diseases prediction by machine learning incorporation with deep learning.

Sivakannan Subramani, Neeraj Varshney, M Vijay Anand, Manzoore Elahi M Soudagar, Lamya Ahmed Al-Keridis, Tarun Kumar Upadhyay, Nawaf Alshammari, Mohd Saeed, Kumaran Subramanian, Krishnan Anbarasu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
47.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Sivakannan SubramaniDepartment of Advanced Computing, St. Joseph's University, Bengaluru, Karnataka, India.
Neeraj VarshneyDepartment of Computer Engineering and Applications, GLA University, Mathura, Uttar Pradesh, India.
M Vijay AnandDepartment of Mechanical Engineering, Kongu Engineering College, Perundurai, Erode, Tamil Nadu, India.
Manzoore Elahi M SoudagarDepartment of VLSI Microelectronics, Saveetha School of Engineering, SIMATS, Chennai, Tamil Nadu, India.
Lamya Ahmed Al-KeridisFaculty of Science, Princess Norah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Tarun Kumar UpadhyayDepartment of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, India.
Nawaf AlshammariDepartment of Biology, College of Science, University of Hail, Hail, Saudi Arabia.
Mohd SaeedDepartment of Biology, College of Science, University of Hail, Hail, Saudi Arabia.
Kumaran SubramanianCentre for Drug Discovery and Development, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
Krishnan AnbarasuDepartment of Bioinformatics, Saveetha School of Engineering, SIMATS, Chennai, Tamil Nadu, India.
Karunakaran RohiniUnit of Biochemistry, Centre of Excellence for Biomaterials Engeneering, Faculty of Medicine, AIMST University, Semeleing, Bedong, Malaysia.
Saveetha University · INUniversity of Ha'il · SAAIMST University · MYGLA University · INMadurai Medical College · INParul University · INPrincess Nourah bint Abdulrahman University · SASathyabama Institute of Science and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is yet unknown what causes cardiovascular disease (CVD), but we do know that it is associated with a high risk of death, as well as severe morbidity and disability. There is an urgent need for AI-based technologies that are able to promptly and reliably predict the future outcomes of individuals who have cardiovascular disease. The Internet of Things (IoT) is serving as a driving force behind the development of CVD prediction. In order to analyse and make predictions based on the data that IoT devices receive, machine learning (ML) is used. Traditional machine learning algorithms are unable to take differences in the data into account and have a low level of accuracy in their model predictions. This research presents a collection of machine learning models that can be used to address this problem. These models take into account the data observation mechanisms and training procedures of a number of different algorithms. In order to verify the efficacy of our strategy, we combined the Heart Dataset with other classification models. The proposed method provides nearly 96 percent of accuracy result than other existing methods and the complete analysis over several metrics has been analysed and provided. Research in the field of deep learning will benefit from additional data from a large number of medical institutions, which may be used for the development of artificial neural network structures.

Indexed as

AI-based technologiescardiovascular diseasecomputational methodinternet of thingsmachine learning

Identifiers

PMID37138750
PMCPMC10150633
OpenAlexW4366086722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.